Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno). Like a ...
Frequency of second- and third-line treatment among elderly Medicare stage IV colon cancer patients. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...
Clinical characterics of mixed neuroendocrine cancer of lung: Retrospective analysis of 20 cases from 2,501 lung cancer. The association between COX-2 polymorphisms and hematologic toxicity in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results